Bladder Cancer‐Derived Small Extracellular Vesicles Promote Tumor Angiogenesis by Inducing HBP‐Related Metabolic Reprogramming and SerRS O‐GlcNAcylation in Endothelial Cells-Reference-Cited by-同舟云学术

Bladder Cancer‐Derived Small Extracellular Vesicles Promote Tumor Angiogenesis by Inducing HBP‐Related Metabolic Reprogramming and SerRS O‐GlcNAcylation in Endothelial Cells

Published:2022-08-31 Issue:30 Volume:9 Page:2202993
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Li Xinyuan¹²³^ORCID,Peng Xiang¹³,Zhang Chunlin¹³,Bai Xuesong¹,Li Yang¹³,Chen Guo¹³,Guo Huixia²,He Weiyang¹,Zhou Xiang¹³,Gou Xin¹

Affiliation:

1. Department of Urology The First Affiliated Hospital of Chongqing Medical University Chongqing 400016 China

2. Centre for Excellence in Molecular Cell Science Shanghai Institute of Biochemistry and Cell Biology Chinese Academy of Sciences Shanghai 200031 China

3. Chongqing Key Laboratory of Molecular Oncology and Epigenetics The First Affiliated Hospital of Chongqing Medical University Chongqing 400016 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202202993

Reference104 articles.

1. Angiogenesis as a therapeutic target in urothelial carcinoma

2. Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer

3. Mechanical Forces in Tumor Angiogenesis

4. Starvation and antimetabolic therapy promote cytokine release and recruitment of immune cells

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The MEF2A/SNHG16/miR-425-5p/NOTCH2 axis induces gemcitabine resistance by inhibiting ferroptosis in the starving bladder tumor microenvironment;Cellular Signalling;2024-10

2. O-GlcNAcylation in tumorigenesis and its implications for cancer therapy;Journal of Biological Chemistry;2024-09

3. Hexokinase HK3-mediated O-GlcNAcylation of EP300: a key regulator of PD-L1 expression and immune evasion in ccRCC;Cell Death & Disease;2024-08-23

4. RhoJ: an emerging biomarker and target in cancer research and treatment;Cancer Gene Therapy;2024-06-10

5. Tumor‐derived hypoxic small extracellular vesicles promote endothelial cell migration and tube formation via ALS2/Rab5/β‐catenin signaling;The FASEB Journal;2024-06-07